Williams SF - Search Results

1

Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation.

Geller RB, Myers S, Devine S, Larson RA, Williams SF, Park CL, O'Toole K, Chandler C, Topper RL. Geller RB, et al. Among authors: williams sf. Bone Marrow Transplant. 1992 Jan;9(1):41-7. Bone Marrow Transplant. 1992. PMID: 1543948 Clinical Trial.

2

Hypersensitivity reaction to high-dose cytarabine.

Williams SF, Larson RA. Williams SF, et al. Br J Haematol. 1989 Oct;73(2):274-5. doi: 10.1111/j.1365-2141.1989.tb00267.x. Br J Haematol. 1989. PMID: 2530999 No abstract available.

3

Source of stem cells impacts on hematopoietic recovery after high-dose chemotherapy.

Zimmerman TM, Mick R, Myers S, Bender JG, Lee WJ, Williams SF. Zimmerman TM, et al. Among authors: williams sf. Bone Marrow Transplant. 1995 Jun;15(6):923-7. Bone Marrow Transplant. 1995. PMID: 7581092 Review.

4

High-dose chemotherapy with autologous stem cell rescue in women with metastatic breast cancer with involved bone marrow: a role for peripheral blood progenitor transplant.

Myers SE, Mick R, Williams SF. Myers SE, et al. Among authors: williams sf. Bone Marrow Transplant. 1994 Apr;13(4):449-54. Bone Marrow Transplant. 1994. PMID: 8019470

5

Guillain-Barré syndrome after autologous bone marrow transplantation for breast cancer: report of two cases.

Myers SE, Williams SF. Myers SE, et al. Among authors: williams sf. Bone Marrow Transplant. 1994 Mar;13(3):341-4. Bone Marrow Transplant. 1994. PMID: 8199578

6

Cyclophosphamide mobilization of peripheral blood stem cells for use in autologous transplantation after high-dose chemotherapy: clinical results in patients with contaminated or hypocellular bone marrow.

Myers SE, Williams SF, Geller RB. Myers SE, et al. Among authors: williams sf. J Hematother. 1992 Spring;1(1):27-33. doi: 10.1089/scd.1.1992.1.27. J Hematother. 1992. PMID: 1365014 Clinical Trial.

7

A pilot study of prophylactic aerosolized amphotericin B in patients at risk for prolonged neutropenia.

Myers SE, Devine SM, Topper RL, Ondrey M, Chandler C, O'Toole K, Williams SF, Larson RA, Geller RB. Myers SE, et al. Among authors: williams sf. Leuk Lymphoma. 1992 Oct;8(3):229-33. doi: 10.3109/10428199209054909. Leuk Lymphoma. 1992. PMID: 1490149 Clinical Trial.

8

Mitoxantrone, vincristine, and 5-fluorouracil with leucovorin modulation as induction chemotherapy prior to high-dose intensification in metastatic breast cancer.

Williams SF, Myers SE, Huffman S, Mick R, Bitran JD. Williams SF, et al. Breast Cancer Res Treat. 1993 Dec;28(3):291-4. doi: 10.1007/BF00666591. Breast Cancer Res Treat. 1993. PMID: 8018957

9

Role of high-dose chemotherapy and autologous stem cell support in treatment of breast cancer.

Myers SE, Williams SF. Myers SE, et al. Among authors: williams sf. Hematol Oncol Clin North Am. 1993 Jun;7(3):631-45. Hematol Oncol Clin North Am. 1993. PMID: 8102137 Review.

10

A phase I-II study of high-dose cyclophosphamide, thiotepa and escalating doses of mitoxantrone with autologous stem cell rescue in patients with refractory malignancies.

Ellis ED, Williams SF, Moormeier JA, Kaminer LS, Bitran JD. Ellis ED, et al. Among authors: williams sf. Bone Marrow Transplant. 1990 Dec;6(6):439-42. Bone Marrow Transplant. 1990. PMID: 1982927 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters